| Aktie | Ticker | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | ||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ Veränd. ($) | Investment ($) | QoQ Veränd. ($) | Investment ($) | QoQ Veränd. ($) | Investment ($) | QoQ Veränd. ($) | ||
| 2.162.580.277 $ | +713.321.118 $ | 1.449.259.159 $ | +137.666.194 $ | 1.342.486.545 $ | +12.539.780 $ | 1.329.946.765 $ | +1.329.946.765 $ | ||
| BANK OF AMERICA CORP /DE/ | BAC | 1.986.342.420 $ | +687.392.109 $ | 1.298.950.311 $ | +494.540.383 $ | 804.409.928 $ | -66.060.013 $ | 870.469.941 $ | +870.469.941 $ |
| MoonLake Immunotherapeutics | MLTX | 57.404.607 $ | +43.106.387 $ | 14.298.220 $ | -386.625.707 $ | 400.923.927 $ | +69.057.447 $ | 331.866.480 $ | +331.866.480 $ |
| INSMED Inc | INSM | 47.861.000 $ | -14.063.300 $ | 61.924.300 $ | +7.578.700 $ | 54.345.600 $ | +14.293.350 $ | 40.052.250 $ | +40.052.250 $ |
| Centessa Pharmaceuticals plc | CNTA | 33.138.250 $ | -13.543.000 $ | 46.681.250 $ | +19.263.326 $ | 27.417.924 $ | -5.103.884 $ | 32.521.808 $ | +32.521.808 $ |
| JPMORGAN CHASE & CO | JPM | 30.893.580 $ | -1.978.120 $ | 32.871.700 $ | +32.871.700 $ | ||||
| GH Research PLC | GHRS | 16.510.000 $ | -10.895.078 $ | 27.405.078 $ | +2.909.492 $ | 24.495.586 $ | +2.331.000 $ | 22.164.586 $ | +22.164.586 $ |
| Ascendis Pharma A/S | ASND | 21.324.000 $ | +21.324.000 $ | ||||||
| 2.162.580.277 $ | +713.321.118 $ | 1.449.259.159 $ | +137.666.194 $ | 1.342.486.545 $ | +12.539.780 $ | 1.329.946.765 $ | +1.329.946.765 $ | ||
Erweiterte Einstellungen
×